Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of HRG2010 in Parkinson's Disease With Motor Fluctuations [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the efficacy and safety of HRG2010 in Parkinson's disease with motor fluctuations and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• HRG2010

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Parkinson's Disease | Phase 3 | Status: RECRUITING